In September 2025, HPQ received strong third-party validation of its silicon-based anode materials initiative through the ...
Phase III is intended to generate meaningful biological data on potential drug compounds prioritized by YuvaBio’s classifier, which applies proprietary machine-learning methods to identify candidates ...
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) (Salarius) announces it will change its corporate name to Decoy Therapeutics Inc. (Decoy) and its common shares will trade on the Nasdaq Capital Market ...
UBER, Lucid and Nuro unveiled their robotaxi design at CES 2026, with testing underway and production set for later this year.
Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for ...
Anticipating mining, energy, and data centre demand, the company targets 20% revenue growth this year.. Gmmco: Shaping ...
4don MSN
After My Baby Died, I Saw 4 Words On A Standard Form At The Doctor's Office That Stopped Me Cold
A minute later, the sound of my name pulled me out of my daze. The nurse stood at the doorway, hand outstretched for my ...
Security Matters PLC is a pre-revenue company specializing in molecular traceability and authentication tech. See why SMX ...
Challenges remain, like regulatory hurdles and funding, but our team's grit and your support as shareholders make me ...
Versant Media Group, Inc.’s IPO signals weak appetite for linear TV and impacts Warner Bros. Discovery, Inc.'s valuation.
Victor Wembanyama's journey to take the next step hits the Christmas stage, where he (and other stars) aim to deliver.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback